Cargando…

Improvement of Vascular Function by Acute and Chronic Treatment with the GPR30 Agonist G1 in Experimental Diabetes Mellitus

The G-protein coupled estrogen receptor 30 (GPR30) is a seven-transmembrane domain receptor that mediates rapid estrogen responses in a wide variety of cell types. This receptor is highly expressed in the cardiovascular system, and exerts vasodilatory effects. The objective of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zi-lin, Liu, Jin-cheng, Liu, Shui-bing, Li, Xiao-qiang, Yi, Ding-hua, Zhao, Ming-gao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367949/ https://www.ncbi.nlm.nih.gov/pubmed/22679517 http://dx.doi.org/10.1371/journal.pone.0038787

Ejemplares similares

Effects of estrogen receptor GPR30 agonist G1 on neuronal apoptosis and microglia polarization in traumatic brain injury rats
por: Pan, Meng-Xian, et al.
Publicado: (2018)

Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Wang, Xuekun, et al.
Publicado: (2022)

Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure
por: Kang, Shoulei, et al.
Publicado: (2012)

GPR30 agonist G1 combined with hypothermia alleviates cognitive impairment and anxiety‐like behavior after subarachnoid hemorrhage in rats
por: Peng, Jun, et al.
Publicado: (2023)

G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation
por: Chakrabarti, Subhadeep, et al.
Publicado: (2012)

G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health
por: Kim, Mi-Jin, et al.
Publicado: (2015)

Multiple tyrosine metabolites are GPR35 agonists
por: Deng, Huayun, et al.
Publicado: (2012)

A Gpr120 Selective Agonist Improves Insulin Resistance and Chronic Inflammation
por: Oh, Da Young, et al.
Publicado: (2014)

Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampal Neuronal Apoptosis in Experimental Vascular Dementia Mice by Promoting GPR30 Expression
por: Shen, Fengming, et al.
Publicado: (2021)

The Cell Surface Estrogen Receptor, G Protein- Coupled Receptor 30 (GPR30), is Markedly Down Regulated During Breast Tumorigenesis
por: Poola, Indira, et al.
Publicado: (2008)

GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021)

GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2
por: Huang, Fang, et al.
Publicado: (2016)

GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol
por: Yates, Melissa A, et al.
Publicado: (2010)

GPR30 Promotes the Phenotypic Switching of Vascular Smooth Muscle Cells via Activating the AKT and ERK Pathways
por: Zha, Binshan, et al.
Publicado: (2020)

GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
por: Mo, Zhiqiang, et al.
Publicado: (2013)

In vivo Effects of a GPR30 Antagonist
por: Dennis, Megan K., et al.
Publicado: (2009)

GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice
por: Ram, Akila, et al.
Publicado: (2021)

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
por: Jala, Venkatakrishna Rao, et al.
Publicado: (2012)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

Discovery of GPR183 Agonists Based on an Antagonist Scaffold
por: Kjær, Viktoria M. S., et al.
Publicado: (2021)

In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
por: Kim, So Ra, et al.
Publicado: (2013)

Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia
por: Wei, Li, et al.
Publicado: (2017)

Hexahydroquinoline Derivatives Are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1/GPR56
por: Vizurraga, Alexander L., et al.
Publicado: (2023)

An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism
por: Lees, Joshua A., et al.
Publicado: (2023)

The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
por: Wei, W, et al.
Publicado: (2014)

GPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
por: Liu, Ruijie, et al.
Publicado: (2020)

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023)

Low concentration of BPA induces mice spermatocytes apoptosis via GPR30
por: Wang, Chaoliang, et al.
Publicado: (2017)

The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages
por: Su, Xing-Li, et al.
Publicado: (2020)

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Activation of the G-protein-coupled receptor GPR30 induces anxiogenic effects in mice, similar to oestradiol
por: Kastenberger, Iris, et al.
Publicado: (2011)

GPR109A and Vascular Inflammation
por: Chai, Joshua T., et al.
Publicado: (2013)

Fluorescent Ligand-Based Discovery of Small-Molecule Sulfonamide Agonists for GPR120
por: Ma, Siyue, et al.
Publicado: (2022)

Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139
por: Shehata, Mohamed A., et al.
Publicado: (2016)

Synergistic effect between LH and estrogen in the acceleration of cumulus expansion via GPR30 and EGFR pathways
por: Liu, Jie, et al.
Publicado: (2020)

Potential roles of GPR120 and its agonists in the management of diabetes
por: Zhang, Dan, et al.
Publicado: (2014)

The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists
por: Deng, Huayun, et al.
Publicado: (2013)

Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
por: Tyurenkov, Ivan N., et al.
Publicado: (2018)

Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer
por: Zhu, Cai-xia, et al.
Publicado: (2017)

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus
por: Naik, H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qnhpp1udveoftnu689ncb8pusi